Prognostic factors for allogeneic haematopoietic cell transplantation outcomes in primary refractory acute myeloid leukaemia (2013–2022): A retrospective study by the adult acute myeloid leukaemia working group of the Japanese Society for Transplantation and Cellular Therapy
British Journal of Haematology · 2025
DOI: 10.1111/bjh.20208 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Haematology, 2025. Verfasst von Takaaki Konuma und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Leukemia, Myeloid, Acute. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: AMED, Japan Agency for Medical Research and Development.
Abstract (Originalsprache)
Primary refractory acute myeloid leukaemia (AML) remains a major clinical challenge, with poor outcomes despite salvage chemotherapy. Allogeneic haematopoietic cell transplantation (HCT) continues to be a potentially curative option for these patients. However, recent data on outcomes and prognostic factors specific to primary refractory AML remain limited. We conducted a retrospective analysis of 2600 adult patients with primary refractory AML who underwent their first allogeneic HCT between 2013 and 2022, using data from the Japanese national registry. The 3‐year overall survival (OS) and leukaemia‐free survival (LFS) rates were 28.5% and 24.4% respectively. The multivariate analysis identified older age (≥50 years), poor performance status (≥2), adverse cytogenetics, extramedullary disease at diagnosis and higher peripheral blood blast count at HCT (≥10%) as significant risk factors for worse OS and LFS. The cumulative incidences of relapse and non‐relapse mortality at 3 years were 49.8% and 25.8% respectively. Based on the five significant risk factors, we developed a scoring system that effectively stratified patients into distinct prognostic groups for OS and LFS. This nationwide analysis demonstrated that allogeneic HCT offers the potential for long‐term survival in adult patients with primary refractory AML. The proposed risk‐scoring system may support clinical decision‐making and patient counselling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
- Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan.
- Division of Hematology, Aichi Medical University, Nagakute, Japan.
- Department of Hematology, St. Mary's Hospital, Kurume, Japan.
- Department of Hematology, Nippon Medical School Hospital, Tokyo, Japan.
- Department of Hematology, Toranomon Hospital, Tokyo, Japan.
ORCID-Profile: Takaaki Konuma, Yoshimitsu Shimomura, Shohei Mizuno, Satoshi Yamasaki, Naoyuki Uchida, Satoshi Yoshihara, Masahito Tokunaga, Shuichi Ota, Yoshinobu Kanda, Junya Kanda, Yoshiko Atsuta, Masamitsu Yanada
Förderung
- AMED
- Japan Agency for Medical Research and Development
Zitieren
APA
Konuma, T., Shimomura, Y., Mizuno, S., Yamasaki, S., Yui, S., Uchida, N., Doki, N., Tanaka, M., Yoshihara, S., Eto, T., Katayama, Y., Katsuoka, Y., Tokunaga, M., Ota, S., Sakata-Yanagimoto, M., Ishiwata, K., Kanda, Y., Kawakita, T., Onizuka, M., …, & Yanada, M. (2025). Prognostic factors for allogeneic haematopoietic cell transplantation outcomes in primary refractory acute myeloid leukaemia (2013–2022): A retrospective study by the adult acute myeloid leukaemia working group of the Japanese Society for Transplantation and Cellular Therapy. British Journal of Haematology. https://doi.org/10.1111/bjh.20208
Vancouver
Konuma T, Shimomura Y, Mizuno S, Yamasaki S, Yui S, Uchida N, et al. Prognostic factors for allogeneic haematopoietic cell transplantation outcomes in primary refractory acute myeloid leukaemia (2013–2022): A retrospective study by the adult acute myeloid leukaemia working group of the Japanese Society for Transplantation and Cellular Therapy. British Journal of Haematology. 2025. doi:10.1111/bjh.20208
BibTeX
@article{Konuma2025,
author = {Konuma, Takaaki and Shimomura, Yoshimitsu and Mizuno, Shohei and Yamasaki, Satoshi and Yui, Shunsuke and Uchida, Naoyuki and Doki, Noriko and Tanaka, Masatsugu and Yoshihara, Satoshi and Eto, Tetsuya and Katayama, Yuta and Katsuoka, Yuna and Tokunaga, Masahito and Ota, Shuichi and Sakata-Yanagimoto, Mamiko and Ishiwata, Kazuya and Kanda, Yoshinobu and Kawakita, Toshiro and Onizuka, Makoto and Kanda, Junya and Fukuda, Takahiro and Atsuta, Yoshiko and Yanada, Masamitsu},
title = {Prognostic factors for allogeneic haematopoietic cell transplantation outcomes in primary refractory acute myeloid leukaemia (2013–2022): A retrospective study by the adult acute myeloid leukaemia working group of the Japanese Society for Transplantation and Cellular Therapy},
journal = {British Journal of Haematology},
year = {2025},
doi = {10.1111/bjh.20208}
}
EUVIMED